Stericycle, Inc., together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services. The company's services also include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, and compliance services; and regulated recall and returns management communication, logistics, and data management services for expired, withdrawn, or recalled products. In addition, it offers compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names; and live voice and automated communication services, including afterhours answering, appointment scheduling, appointment reminders, secure messaging, and event registration. The company serves healthcare businesses, including hospitals, physician and dental practices, outpatient clinics, long-term care facilities, etc.; retailers and manufacturers; financial and professional service providers; governmental entities; and other businesses. Stericycle, Inc. was founded in 1989 and is based in Lake Forest, Illinois.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Sanitary services
Sub-IndustryEnvironmental & Facilities Services
SectorBusiness Services
SymbolNASDAQ:SRCL
CUSIP85891210
Phone847-367-5910
Debt
Debt-to-Equity Ratio0.88
Current Ratio0.81
Quick Ratio0.81
Price-To-Earnings
Trailing P/E Ratio15.73
Forward P/E Ratio14.74
P/E Growth1.51
Sales & Book Value
Annual Sales$3.58 billion
Price / Sales1.63
Cash Flow$7.6172 per share
Price / Cash8.96
Book Value$34.07 per share
Price / Book2.00
Profitability
EPS (Most Recent Fiscal Year)$4.34
Net Income$42.40 million
Net Margins0.19%
Return on Equity14.14%
Return on Assets5.76%
Miscellaneous
Employees645
Outstanding Shares85,580,000
Market Cap$5,772.14
Stericycle (NASDAQ:SRCL) Frequently Asked Questions
What is Stericycle's stock symbol?
Stericycle trades on the NASDAQ under the ticker symbol "SRCL."
How were Stericycle's earnings last quarter?
Stericycle Inc (NASDAQ:SRCL) announced its earnings results on Thursday, May, 3rd. The business services provider reported $1.21 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.05 by $0.16. The business services provider had revenue of $895 million for the quarter, compared to analyst estimates of $880.48 million. Stericycle had a return on equity of 14.14% and a net margin of 0.19%. The business's revenue was up .3% on a year-over-year basis. During the same quarter last year, the firm posted $1.09 EPS. View Stericycle's Earnings History.
When is Stericycle's next earnings date?
What guidance has Stericycle issued on next quarter's earnings?
Stericycle issued an update on its FY18 earnings guidance on Thursday, May, 3rd. The company provided earnings per share guidance of $4.45-$4.85 for the period, compared to the Thomson Reuters consensus estimate of $4.50. The company issued revenue guidance of $3.5-$3.64 billion, compared to the consensus revenue estimate of $3.55 billion.
What price target have analysts set for SRCL?
8 analysts have issued twelve-month price targets for Stericycle's shares. Their forecasts range from $61.00 to $100.00. On average, they anticipate Stericycle's share price to reach $78.2857 in the next twelve months. This suggests a possible upside of 14.7% from the stock's current price. View Analyst Ratings for Stericycle.
What is the consensus analysts' recommendation for Stericycle?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stericycle in the last year. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
Who are some of Stericycle's key competitors?
Who are Stericycle's key executives?
Stericycle's management team includes the folowing people:
- Mr. Charles A. Alutto, Pres, CEO & Director (Age 52)
- Mr. Daniel V. Ginnetti, Exec. VP & CFO (Age 49)
- Mr. Joseph Arnold, Exec. VP & COO (Age 49)
- Ms. Ruth-Ellen Abdulmassih, Exec. VP of Communication & Related Services (Age 56)
- Ms. Brenda R. Frank, Exec. VP & Chief People Officer (Age 48)
Has Stericycle been receiving favorable news coverage?
News articles about SRCL stock have trended somewhat positive on Friday, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Stericycle earned a news impact score of 0.15 on Accern's scale. They also gave news headlines about the business services provider an impact score of 45.46 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.
Who are Stericycle's major shareholders?
Stericycle's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Baillie Gifford & Co. (2.99%), Clarkston Capital Partners LLC (2.91%), Bank of Montreal Can (0.21%), Capital Investment Services of America Inc. (0.18%), Smith Graham & Co. Investment Advisors LP (0.14%) and Welch & Forbes LLC (0.08%). Company insiders that own Stericycle stock include Charles A Alutto, Jack W Schuler, John P Schetz, John Patience, Mark C Miller, Mike S Zafirovski, Robert S Murley, Rodney F Dammeyer and Thomas D Brown. View Institutional Ownership Trends for Stericycle.
Which institutional investors are selling Stericycle stock?
SRCL stock was sold by a variety of institutional investors in the last quarter, including Welch & Forbes LLC, Baillie Gifford & Co., Hartford Investment Management Co., Bank of Montreal Can, Gofen & Glossberg LLC IL, Osborne Partners Capital Management LLC, Winslow Evans & Crocker Inc. and TNB Financial. Company insiders that have sold Stericycle company stock in the last year include Charles A Alutto, John Patience, Mark C Miller and Thomas D Brown. View Insider Buying and Selling for Stericycle.
Which institutional investors are buying Stericycle stock?
SRCL stock was acquired by a variety of institutional investors in the last quarter, including Nelson Roberts Investment Advisors LLC, Capital Investment Services of America Inc., Clarkston Capital Partners LLC, Cornerstone Wealth Management LLC, DnB Asset Management AS, Amalgamated Bank, Radnor Capital Management LLC and Smith Graham & Co. Investment Advisors LP. Company insiders that have bought Stericycle stock in the last two years include Jack W Schuler, Mike S Zafirovski and Robert S Murley. View Insider Buying and Selling for Stericycle.
How do I buy shares of Stericycle?
Shares of SRCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Stericycle's stock price today?
One share of SRCL stock can currently be purchased for approximately $68.24.
How big of a company is Stericycle?
Stericycle has a market capitalization of $5.77 billion and generates $3.58 billion in revenue each year. The business services provider earns $42.40 million in net income (profit) each year or $4.34 on an earnings per share basis. Stericycle employs 645 workers across the globe.
How can I contact Stericycle?
Stericycle's mailing address is 28161 NORTH KEITH DRIVE, LAKE FOREST IL, 60045. The business services provider can be reached via phone at 847-367-5910 or via email at [email protected]
MarketBeat Community Rating for Stericycle (NASDAQ SRCL)
MarketBeat's community ratings are surveys of what our community members think about Stericycle and other stocks. Vote "Outperform" if you believe SRCL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRCL will underperform the S&P 500 over the long term. You may vote once every thirty days.
